SCHEMBL2354029

SCHEMBL2354029

COc1cc(F)c(-c2c(Cl)nnc(C)c2-c2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
GPR55 Q9Y2T6 2/20 0.38
CYP1A2 P05177 2/20 0.38
ALOX12 P18054 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
GLA P06280 1/20 0.36
FPR2 P25090 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
FPR1 P21462 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13165379 0.93 MEN1 (0.47) MEN1KMT2ACNR1CNR2GPR55
SCHEMBL2356139 0.89 MEN1 (0.36) MEN1KMT2ACYP1A2MAPTTP53
SCHEMBL12394014 0.88 MEN1 (0.49) MEN1KMT2ACNR1CNR2GPR55
SCHEMBL1162374 0.87 CYP1A2 (0.37) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL2347440 0.86 NPC1 (0.39) MEN1KMT2ACYP1A2KDM4ENPSR1
SCHEMBL2322978 0.86 GRM8 (0.32) MEN1KMT2ACYP1A2GRM8GRM7
SCHEMBL13697333 0.86 MEN1 (0.35) MEN1KMT2ACYP1A2KDM4EMAPT
SCHEMBL1869939 0.86 RAB9A (0.36) MEN1KMT2AMAPTLMNATP53
SCHEMBL2351308 0.86 CACNA2D1 (0.42) MEN1KMT2ACYP1A2KDM4ECYP2D6
SCHEMBL2322837 0.85 PDE2A (0.32) MEN1KMT2ACYP1A2GRM8GRM7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008512-B2 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-30 US disclosed
US-8008512-B2 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-30 US disclosed
US-8008512-B2 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-30 US disclosed
US-20100130359-A1 Fungicidal Pyridazines, Processes for Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising Them BASF SE (DE) 2010-05-27 US disclosed
US-20090281337-A1 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2009-11-12 US disclosed
US-20090281337-A1 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2009-11-12 US disclosed
US-20090281337-A1 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2009-11-12 US disclosed
US-7569518-B2 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-04 US disclosed
US-7569518-B2 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-04 US disclosed
US-7569518-B2 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-04 US disclosed
EP-1767529-B1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2009-05-06 EP disclosed
EP-1767529-B1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2009-05-06 EP disclosed
US-20080194566-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-08-14 US disclosed
US-20080194566-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-08-14 US disclosed
US-20080194566-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-08-14 US disclosed
EP-1767529-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-03-28 EP disclosed
EP-1767529-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194566-A1 Pyridazine Compound and Use Thereof PLPBP, PNPO, CYP4Z1 MEN1 2346/4885KMT2A 2463/4885CNR1 283/4885
US-20090281337-A1 Pyridazine compound and use thereof PLPBP, PNPO, CYP4Z1 MEN1 2346/4885KMT2A 2463/4885CNR1 283/4885
US-20100130359-A1 Fungicidal Pyridazines, Processes for Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising Them PNPO, CYP4Z1, CYP3A5 MEN1 321/4885KMT2A 2183/4885CNR1 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.